Statement of Changes in Beneficial Ownership (4)
January 05 2021 - 6:54PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
GELFOND RICHARD L |
2. Issuer Name and Ticker or Trading Symbol
IMAX CORP
[
IMAX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer |
(Last)
(First)
(Middle)
902 BROADWAY, 20TH FLOOR |
3. Date of Earliest Transaction
(MM/DD/YYYY)
1/2/2021 |
(Street)
NEW YORK 10010-6002
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
common shares (opening balance) | | | | | | | | 296992 | D | |
common shares | 1/2/2021 | | M | | 44715 (1) | A | $0.00 | 341707 | D | |
common shares | 1/2/2021 | | F | | 17617 (2) | D | $18.02 | 324090 (6) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
restricted share units (3) | $0.00 (4) | 1/2/2021 | | M | | | 44715 (1) | (5) | (5) | common shares | 44715 | $0.00 (4) | 89431 (6) | D | |
Explanation of Responses: |
(1) | Represents the conversion of vested restricted share units into common shares. |
(2) | Mr. Gelfond is reporting the withholding by IMAX Corporation of 17,617 common shares to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transaction. |
(3) | Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. |
(4) | Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. |
(5) | The restricted share units vest and are converted to common shares in three installments: 44,715 on each of January 2, 2021 and January 2, 2022 and 44,716 on January 2, 2023. |
(6) | This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 3,396,343; 89,431 and 324,090, respectively. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
GELFOND RICHARD L 902 BROADWAY 20TH FLOOR NEW YORK 10010-6002 | X |
| Chief Executive Officer |
|
Signatures
|
/s/ Richard L. Gelfond | | 1/5/2021 |
**Signature of Reporting Person | Date |
IMAX (NYSE:IMAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
IMAX (NYSE:IMAX)
Historical Stock Chart
From Sep 2023 to Sep 2024